HomeCARA • NASDAQ
Cara Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.46M | -51.56% |
Operating expense | 7.00M | -9.36% |
Net income | -7.68M | 76.25% |
Net profit margin | -527.77 | 50.97% |
Earnings per share | — | — |
EBITDA | -6.00M | 81.55% |
Effective tax rate | 4.93% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 37.90M | -62.38% |
Total assets | 43.83M | -65.17% |
Total liabilities | 48.42M | -29.58% |
Total equity | -4.59M | — |
Shares outstanding | 4.57M | — |
Price to book | -5.06 | — |
Return on assets | -31.53% | — |
Return on capital | -35.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.68M | 76.25% |
Cash from operations | -4.04M | 76.72% |
Cash from investing | 5.00M | 116.55% |
Cash from financing | -1.62M | -104.43% |
Net change in cash | -658.00K | 94.07% |
Free cash flow | -14.66M | -58.40% |
Previous close
$5.06
Day range
$5.00 - $5.13
Year range
$2.71 - $11.52
Market cap
23.45M USD
Avg Volume
16.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
10
